REDDSTAR’s fifth plenary meeting was held at the Merchant Hotel in Belfast, Northern Ireland, UK on 29 April 2015. In the morning, the six scientists involved in the preclinical work packages that focus on complications of diabetes presented an update since our last meeting. Future plans were discussed, including experiments focusing on the mechanism of action studies of the CD362+ MSC cells.
In the afternoon, the StudyVault, GMP production and the clinical trial timeline and logistics were discussed. In addition, time was allocated to the coordination, management, dissemination and exploitation aspects of REDDSTAR. The meeting ended with a publication planning session focusing on initial consortium papers that would best describe the novel and exciting data that has been generated from the REDDSTAR project.